GMED stock forecast
Our latest prediction for Globus Medical, Inc.'s stock price was made on the July 17, 2018 when the stock price was at 52.88$.
In the short term (2weeks), GMED's stock price should outperform the market by 0.30%. During that period the price should oscillate between -4.26% and +4.31%.
In the medium term (3months), GMED's stock price should outperform the market by 0.82%. During that period the price should oscillate between -10.81% and +12.55%.Get email alerts
Create a solid portfolio with GMED
About Globus Medical, Inc.
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
At the moment the company generates 770M USD in revenues.
On its last earning announcement, the company reported a profit of 1.44$ per share.
The book value per share is 11.17$
Three months stock forecastJuly 17, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|